Helsinn Group Announces The Launch Of The Iv Formulation Of Akynzeo® İn The United States8 Mayıs 2018 16:24 Güncel Haberler Helsinn Group announces the launch of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States.Helsinn Group announces the launch of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States. HABERİN DEVAMINI OKU Kaynak: Demirören Haber Ajansı / Güncel Politika, Güncel, Haberler